Effect of virechana Karma With trivrit Churna in Vatarakta w.s.r to Gout.

Phase 2

Conditions: Health Condition 1: M109- Gout, unspecified

Registration Number: CTRI/2024/05/067375

Lead Sponsor: DrAditya Prasad Satapathy

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Patients having Serum uric acid conc. more than 7.0mg/dl in male and more than 6.0 mg/dl in female. Patients having their age more than 18 years and below 70 years.

Patients having sign & symptoms of vatarakta (Gout).

All three essential symptoms with or without non-essential symptoms. Essential criteria:-

1. pain in affected joint.

2.swelling in the affected joint.

3.loss of tactile sensation. Non-essential criteria:-

1.redness in affected joint.

2.itching in affected joint.

3.burning sensation over joint.

4.discoloration of skin of affected joint.

Exclusion Criteria

Patients of age below 18 and above 70 years.

Patients having complications of vatarakta (upadrava) like, moorcha, hikka etc.

Patients having secreting tophus.

Patients associated with HIV, Hepatitis and also pregnant women.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The improvement in the patients will be assessed mainly on the basis of relief in the cardinal symptoms of disease. To access the effect of therapy subjectively, all the sign & symptoms will be relief in <br/ ><br>1.pain in affected joint. <br/ ><br>2.swelling in the affected joint. <br/ ><br>3.laws of tactile sensation. upon their severity.Timepoint: 55days

Secondary Outcome Measures

Name	Time	Method
The analysis of the values of the serum uric acid will be done before & after the treatment and during the follow up to compare the condition of affected joints.Timepoint: 55days